Napp Pharmaceuticals Ltd

Napp has grown up with the NHS, providing innovative medicines to patients in the UK since the 1920s. We know how to navigate its complexities and we’ve shaped our structure to its unique needs, so as the NHS changes, we can too.

We foster a flexible culture at Napp where our people thrive on the ability to be agile and autonomous in response to the needs of our partners.

From launching the UK’s first monoclonal antibody biosimilar to introducing cutting-edge primary care medicines in respiratory and diabetes, we are always striving to move medicine forward for doctors and patients in the UK.